Board of Directors
Paul Geyer - Executive Chair
For more than 25 years, Paul Geyer has been a prolific Medtech entrepreneur, board member and angel investor in the Vancouver area. In 1991, he founded Mitroflow, a tissue heart valve company. Following the successful sale of Mitroflow, Paul started Medical Ventures (Neovasc), where he is currently Chairman of the Board. Mr. Geyer held the position of CEO at Neovasc until June 2008 and was responsible for raising over $40 million in equity financing and the acquisition of 3 other companies. Paul is actively engaged in the community as a philanthropist, Chairman of the Board of Social Venture Partners Vancouver, a board member of the BC Tech Association, a G7 fellow with Creative Destruction Labs, and is involved with numerous other organizations. Along with Dr. Maurer, Paul is a founding member of LightIntegra Technology and led as its CEO until March 2017 when Bill Dubiel was brought on and Paul assumed his role as Executive Chair
Dr. Elisabeth Maurer is the principal inventor of ThromboLUX and the founder of LightIntegra Technology. Elisabeth has over twenty years of research experience devoting her career to understanding platelet function and the application of dynamic light scattering. She was a scientist with Canadian Blood Services and holds the position of Adjunct Scientist with CBS since 2010. Elisabeth also holds a position as Clinical Associate Professor with the University of British Columbia and is an active member of a number of organizations with a focus on blood transfusion such as AABB, CSTM, ISBT and the UBC CBR. She received her Ph.D. in physical chemistry from the Karl-Franzens University in Graz, Austria.
Bill brings more than 28 years of experience in the medical device industry, and extensive commercial knowledge, to LightIntegra. He has held senior level positions at Personal Genome Diagnostics, CyVek, Ventana, Roche, Bayer and Chiron Diagonstics. During his career he has successfully launched 5 uniquely innovative technologies in the clinical and life science segment. Bill has an excellent track record in bringing rapid success to start-ups. He successfully exited a biotechnology start-up company for over $105 million within 6 months of the product launch. He as also assisted in the commercial launch of two other medical device start-ups, collectively gaining over $80 million in series B funding.
Brent was an early employee at MDI Mobile Data International, where he pioneered the marketing of wireless communications into the North American utility industry. Subsequent to MDI, Brent was a co-founder of MDSI Mobile Data Solutions Inc., a leading provider of wireless workforce management solutions in the utilities and telecommunications industries worldwide. MDSI went public on NASDAQ in the late 1990’s and has since been taken private again. Following MDSI, Brent became the first CEO of Abebooks.com, one of the world’s largest Internet sources of used, rare, and out-of-print books. Abebooks was sold to Amazon in a transaction that provided healthy returns for founders, employees, and investors. Brent is currently the President and CEO of Aquila Diagnostic Systems Inc. Aquila is commercializing its patented solutions for point-of-care DNA/RNA diagnostic testing.
Geof has been involved in the medical device industry since the early 1980s with projects ranging from laboratory automation systems to the development of the world’s first surgical robot. In 1997, Geof founded Neoteric Technology Ltd., a company providing systems for managing blood products in hospitals. He managed and grew the company until its sale in 2009. Since 1990, Geof has served on the Board of Directors of Vancouver’s Medical Device Development Centre, including 22 years as chair. Currently, Geof is Chairman and CEO of Claris Healthcare Inc., he also currently serves on the board of the AceTech Academy for Technology CEOs and as an independent board member of two other medical device companies. Geof studied Engineering Physics at the University of British Columbia and holds 20 US patents on a wide range of inventions.
Andrew brings with him an enormous breadth of experience. He started his career as a co-founder of Zaber Technologies and worked at Creo Technologies in Vancouver. Following this, he completed General Electric’s Experienced Commercial Leadership Program and spent 7 years at GE in a variety of positions ultimately leading business development for GE Healthcare’s Europe, Middle East, & Africa business and GE Healthcare’s Life Sciences business based in London, UK. Andrew holds a degree in Engineering Physics from UBC and an MBA from INSEAD in France. Andrew is currently the Chief Commercial Officer at STEMCELL Technologies, Canada’s largest biotech company. Before becoming CCO, Andrew had been the CFO at STEMCELL for nearly 4 years and, prior to that, he led the formation of STEMCELL’s Instrumentation Division. Andrew is also a board member of Life Sciences BC, the BC Tech Association, Precision Nanosystems, Abcellera, a mentor for the New Ventures BC business plan competition, and a member of the fundraising board for Science World.
James LaFrance joined the Board of LightIntegra Technology in February 2018, bringing extensive US experience in the diagnostics industry. Jim has had CEO experience at both Omnyx, LLC for GE Healthcare and with Vermillion, Inc. He held a series of commercial leadership, strategic marketing and business development leadership roles at Ventana Medical Systems (now Roche Tissue Diagnostics). Prior to Ventana, Mr. LaFrance served in leadership roles in strategic marketing and business development at Bayer Diagnostics. Jim currently serves as Chairman of the Board of Vermillion, Inc. as well as Bioarray.us. He is also a Director of HTG Molecular Diagnostics, and Personal Genome Diagnostics. Jim earned a Bachelor of Arts degree in Economics from the University of Connecticut and an MBA from the University of Notre Dame.